BR102375 is a non-TZD peroxisome proliferator-activated receptor γ ( PPAR γ ) full agonist for the treatment of type 2 diabetes, reveals EC 50 value of 0.28 μM and A max ratio of 98%.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PARP | Products > Signaling Pathways > Apoptosis
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。